Research Output per year
Research Output 1992 2010
- 8 Article
2010
Pegfilgrastim appears equivalent to daily dosing of filgrastim to treat neutropenia after autologous peripheral blood stem cell transplantation in patients with non-hodgkin lymphoma
Rifkin, R., Spitzer, G., Orloff, G., Mandanas, R., McGaughey, D., Zhan, F., Boehm, K. A., Asmar, L. & Beveridge, R., Jan 1 2010, In : Clinical Lymphoma, Myeloma and Leukemia. 10, 3, p. 186-191 6 p.Research output: Contribution to journal › Article
Peripheral Blood Stem Cell Transplantation
Neutropenia
Non-Hodgkin's Lymphoma
Carmustine
Erythrocyte Transfusion
2006
Ovarian cancer care: A case study in determined living
Umlauf, R. L. & Orloff, G., Jan 1 2006, In : Onkologie. 29, 1-2, p. 27-29 3 p.Research output: Contribution to journal › Article
Ovarian Neoplasms
Hospice Care
Quality of Life
Palliative Care
Therapeutics
2005
Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation
Loren, A. W., Luger, S. M., Stadtmauer, E. A., Tsai, D. E., Schuster, S., Nasta, S. D., Goldstein, S. C., Perl, A., Orloff, G., Oliver, J. C., Green, J., Emerson, S. G. & Porter, D. L., May 1 2005, In : Bone Marrow Transplantation. 35, 9, p. 921-926 6 p.Research output: Contribution to journal › Article
Unrelated Donors
Stem Cell Transplantation
Graft vs Host Disease
Cyclosporine
Methotrexate
2001
Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation
Porter, D. L., Luger, S. M., Duffy, K. M., Stadtmauer, E. A., Laport, G., Schuster, S. J., Orloff, G., Tsai, D., McDaid, K., Kathakali, A., Leonard, D. G. B. & Antin, J. H., Jan 1 2001, In : Biology of Blood and Marrow Transplantation. 7, 4, p. 230-238 9 p.Research output: Contribution to journal › Article
Stem Cell Transplantation
Cell- and Tissue-Based Therapy
Recurrence
Chimerism
Graft vs Host Disease
2000
Allogeneic cell therapy (act) after relapse from autologous stem cell transplantation (autosct)
Porter, D., Luger, S., Duffy, K., Orloff, G., Tsai, D., Stadtmauer, E., Laport, G., Schuster, S. & McDaid, K., Dec 1 2000, In : Blood. 96, 11 PART IResearch output: Contribution to journal › Article
Stem Cell Transplantation
Cell- and Tissue-Based Therapy
Stem cells
Chimerism
Tissue Donors
1996
Regulation of interleukin-1β-stimulated inducible nitric oxide synthase expression in cultured vascular smooth muscle cells by hemostatic proteins
Durante, W., Kroll, M. H., Orloff, G., Cunningham, J. M., Scott-Burden, T., Vanhoutte, P. M. & Schafer, A. I., Mar 22 1996, In : Biochemical Pharmacology. 51, 6, p. 847-853 7 p.Research output: Contribution to journal › Article
Nitric Oxide Synthase Type II
Hemostatics
Interleukin-1
Vascular Smooth Muscle
Smooth Muscle Myocytes
1994
Donor mononuclear cell infusions as therapy for B-cell lymphoproliferative disorder following allogeneic bone marrow transplant.
Porter, D. L., Orloff, G. & Antin, J. H., Sep 1 1994, In : Transplantation science. 4, 1, p. 12-14 3 p.Research output: Contribution to journal › Article
Tumor Virus Infections
Leukocyte Transfusion
Mononuclear Leukocytes
Herpesviridae Infections
Acute Promyelocytic Leukemia
1992
Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line
Lyons, C. R., Orloff, G. & Cunningham, J. M., Jan 1 1992, In : Journal of Biological Chemistry. 267, 9, p. 6370-6374 5 p.Research output: Contribution to journal › Article
Macrophages
Cloning
Molecular Cloning
Nitric Oxide Synthase Type II
Nitric Oxide Synthase